CorMedix appoints director
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Sustainability Outlook
The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism
CorMedix Inc.'s board elected Gary Gelbfish as a director, effective Aug. 3, to serve until the 2018 annual meeting.
Gelbfish currently serves as CEO and chairman of Metrodora Therapeutics LLC, a clinical stage biotechnology company.
